NAFLD pathophysiologic processes linking obesity enhanced circulating concentrations of pro-inflammatory cytokines and factors (e.g., TNF-α, IL-6 and IL-1β). The gene discussed is IL1B; the disease is metabolic dysfunction-associated steatotic liver disease.